Detalhe da pesquisa
1.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820078
2.
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.
Future Oncol
; 18(36): 3961-3969, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377973
3.
A randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced cancer: study protocol.
BMC Palliat Care
; 21(1): 198, 2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384735
4.
Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study.
Br J Haematol
; 192(4): 737-746, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095453
5.
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).
Br J Haematol
; 188(2): 240-248, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879945
6.
Inflammatory manifestations in patients with Shwachman-Diamond syndrome: A novel phenotype.
Am J Med Genet A
; 182(7): 1754-1760, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293785
7.
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Br J Haematol
; 184(2): 215-222, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30183069
8.
A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): study protocol.
BMC Cancer
; 19(1): 89, 2019 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658621
9.
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
Am J Hematol
; 92(11): 1214-1223, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28815757
10.
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 17(5): 612-21, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083332
11.
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.
Future Oncol
; 12(15): 1759-68, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27093976
12.
Insights into lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentary.
Clin Adv Hematol Oncol
; 16 Suppl 16(9): 13-15, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807557
13.
Anxiety and Depression in Metastatic Cancer: A Critical Review of Negative Impacts on Advance Care Planning and End-of-Life Decision Making With Practical Recommendations.
JCO Oncol Pract
; 19(12): 1097-1108, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831973
14.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem
; 3(2): 394-405, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846031
15.
Randomized trial of acceptance and commitment therapy for anxious cancer survivors in community clinics: Outcomes and moderators.
J Consult Clin Psychol
; 89(4): 327-340, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014694
16.
Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(4): e214103, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877311
17.
Acceptability, Feasibility, and Efficacy Potential of a Multimodal Acceptance and Commitment Therapy Intervention to Address Psychosocial and Advance Care Planning Needs among Anxious and Depressed Adults with Metastatic Cancer.
J Palliat Med
; 23(10): 1380-1385, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905307
18.
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
J Clin Oncol
; 31(33): 4199-206, 2013 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24127452
19.
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders.
Clin Cancer Res
; 18(20): 5752-60, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22893631
20.
Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Clin Cancer Res
; 17(13): 4232-44, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540239